News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
March, 2025
March 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  
Julie Sosa: Clinically motivated NGS analysis suggests RETM918T may not portend the compromised outcomes expected
Jun 13, 2024, 13:50

Julie Sosa: Clinically motivated NGS analysis suggests RETM918T may not portend the compromised outcomes expected

Julie Sosa, Chair of Department of Surgery at UCSF Health, shared on X/Twitter:

“Clinically motivated NGS analysis with a medullary thyroid CA registry from MD Anderson Cancer Center, UCSF Surgery suggests RETM918T may not portend the compromised outcomes expected. Thanks for the feature Endocrine Society, Endocrine Society Journals!”

Visit the article website.
Source: Julie Sosa/X

cancer Endocrine Society Endocrine Society Journals Julie Sosa MD Anderson Cancer Center NGS analysis OncoDaily Oncology UCSF Surgery
Special Coverage
Opinion
Feb 28, 2025, 18:34
Does Sunscreen Cause Cancer? Myths and Facts about Sunscreen and Cancer
Blog
Feb 28, 2025, 15:34
CancerWorld welcomes their Co-Editors-in-Chief
Blog
Feb 28, 2025, 15:33
PTCy-based GVH disease prophylaxis for matched sibling donor - IACH
Blog
Feb 28, 2025, 15:25
NanCI: Connecting Scientists Gets New Features - Train at NCI
Blog
Feb 28, 2025, 15:22
Javier Cortes about value of global collaboration at EIOC 2024
Blog
Feb 28, 2025, 15:20
Dr. Tori Willard Early Career Award: Call for Proposals - SIOP
Blog
Feb 28, 2025, 15:13
Lucas’s journey with acute lymphoblastic leukemia - St. Baldrick's Foundation
Blog
Feb 28, 2025, 15:12
Catherine Alix-Panabières: Honored to welcome Key International Experts in Liquid Biopsy from 14 different countries
Blog
Feb 28, 2025, 15:02
Best registration rates for ESMO Breast 25 before 6 March
Blog
Feb 28, 2025, 14:50
Elvina Almuradova: The FDA has granted fast track designation to 67Cu-SAR-bisPSMA for PSMA-positive mCRPC
Science
Feb 28, 2025, 14:43
Drew Moghanaki: Why there is a desire to deliver SBRT to ultra-central tumors
Science
Feb 28, 2025, 14:37
Yan Leyfman: Promising Results for Sickle Cell Transplant